GENETICALLY MODIFIED RHESUS MONKEYS

转基因恒河猴

• 批准号: 7561889
• 负责人: SHOUKHRAT M MITALIPOV
• 金额: $ 7.59万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-05-01 至 2008-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7561889
• 关键词: Animals; Ataxia Telangiectasia; Cloning; Computer Retrieval of Information on Scientific Projects Database; Condition; Disease; Funding; Gene Targeting; Goals; Grant; Human; Institution; Kallmann Syndrome; Lesch-Nyhan Syndrome; Macaca mulatta; Modeling; Research; Research Personnel; Resources; Somatic Cell; Source; Technology; United States National Institutes of Health; Work; base; early onset; human disease; loss of function; neurogenetics

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The long-term goal is to produce genetically-modified rhesus monkeys that will serve as models for human neurogenetic diseases. Our working hypothesis is that gene targeting and somatic cell cloning technology can, in combination, provide the basis for generating a reliable supply of animals that accurately represent human disease. We will focus on three, early-onset, loss-of-function conditions: Kallmann's syndrome, Lesch-Nyhan's disease and Ataxia-Telangiectasia.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 长期目标是生产转基因恒河猴，作为人类神经遗传性疾病的模型。 我们的工作假设是，基因靶向和体细胞克隆技术相结合，可以为产生准确代表人类疾病的可靠动物供应提供基础。 我们将重点关注三种早发性功能丧失的情况： Kallmann综合征、Lesch-Nyhan病和共济失调-毛细血管扩张症。